Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.19.3
Accrued Expenses
 9 Months Ended
Sep. 30, 2019
Accrued Expenses  
Accrued Expenses

4. Accrued Expenses

Accrued expenses at September 30, 2019 and December 31, 2018 consist of the following:

 

 

 

 

 

 

 

 

 

 

September 30, 

 

 

 

 

 

2019

 

December 31, 

 

    

(unaudited)

    

2018

Payroll and Benefits

 

$

507,256

 

$

722,178

Clinical Trials

 

 

298,290

 

 

212,540

Professional Fees

 

 

172,396

 

 

165,894

Consulting

 

 

4,653

 

 

9,401

Short-Term Portion of Capital Financing Obligation

 

 

 —

 

 

4,715

Total Accrued Expenses

 

$

982,595

 

$

1,114,728